Immunometabolism in atherosclerotic disorders
- 23 May 2024
- journal article
- review article
- Published by Springer Nature in Nature Cardiovascular Research
- Vol. 3 (6) , 637-650
Abstract
Cardiovascular diseases (CVDs), including atherosclerosis, myocardial infarction and heart failure, are the leading causes of morbidity and mortality worldwide. Emerging evidence suggests a crucial role for immune cell dysfunction and inflammation in the progression of this complex set of diseases. Recent advances demonstrate that immune cells, tightly linked to CVD pathogenesis, are sensitive to environmental signals and respond by engaging immunometabolic networks that shape their behavior. Inflammatory cues and altered nutrient availability within atherosclerotic plaques or following ischemia synergize to elicit metabolic shifts in immune cells that influence the course of disease pathology. Understanding these metabolic adaptations and how they contribute to cellular dysfunction may reveal novel therapeutic approaches for the treatment of CVD. Here we provide a comprehensive summary of the metabolic reprogramming that occurs in immune cells and their progenitors during CVD, offering insights into the potential therapeutic interventions to mitigate disease progression.Keywords
Funding Information
- Department of Health | National Health and Medical Research Council (GNT1194329, GNT202152, GNT2017335, GNT2012119)
- Diabetes Australia Research Trust
This publication has 149 references indexed in Scilit:
- Atherosclerosis: Recent developmentsCell, 2022
- Metabolic modeling of single Th17 cells reveals regulators of autoimmunityCell, 2021
- De novo polyamine synthesis supports metabolic and functional responses in activated murine NK cellsEuropean Journal of Immunology, 2020
- Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent MetabolismCell, 2018
- Western Diet Triggers NLRP3-Dependent Innate Immune ReprogrammingCell, 2018
- L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor ActivityCell, 2016
- Caloric Restriction Mimetics Enhance Anticancer ImmunosurveillanceCancer Cell, 2016
- Leptin directly promotes T‐cell glycolytic metabolism to drive effector T‐cell differentiation in a mouse model of autoimmunityEuropean Journal of Immunology, 2016
- Association of Leukocyte and Neutrophil Counts With Infarct Size, Left Ventricular Function and Outcomes After Percutaneous Coronary Intervention for ST-Elevation Myocardial InfarctionThe American Journal of Cardiology, 2009
- LXR Signaling Couples Sterol Metabolism to Proliferation in the Acquired Immune ResponseCell, 2008